These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
530 related articles for article (PubMed ID: 29727835)
1. Amorphous ternary nanoparticle complex of curcumin-chitosan-hypromellose exhibiting built-in solubility enhancement and physical stability of curcumin. Lim LM; Tran TT; Long Wong JJ; Wang D; Cheow WS; Hadinoto K Colloids Surf B Biointerfaces; 2018 Jul; 167():483-491. PubMed ID: 29727835 [TBL] [Abstract][Full Text] [Related]
2. Effects of chitosan molecular weight on the physical and dissolution characteristics of amorphous curcumin-chitosan nanoparticle complex. Yu H; Nguyen MH; Hadinoto K Drug Dev Ind Pharm; 2018 Jan; 44(1):82-88. PubMed ID: 28849675 [TBL] [Abstract][Full Text] [Related]
3. Cost-effective alternative to nano-encapsulation: Amorphous curcumin-chitosan nanoparticle complex exhibiting high payload and supersaturation generation. Nguyen MH; Yu H; Kiew TY; Hadinoto K Eur J Pharm Biopharm; 2015 Oct; 96():1-10. PubMed ID: 26170159 [TBL] [Abstract][Full Text] [Related]
4. A simple strategy to enhance the in vivo wound-healing activity of curcumin in the form of self-assembled nanoparticle complex of curcumin and oligochitosan. Nguyen MH; Lee SE; Tran TT; Bui CB; Nguyen TH; Vu NB; Tran TT; Nguyen TH; Nguyen TT; Hadinoto K Mater Sci Eng C Mater Biol Appl; 2019 May; 98():54-64. PubMed ID: 30813056 [TBL] [Abstract][Full Text] [Related]
5. Enhancing the physical stability and supersaturation generation of amorphous drug-polyelectrolyte nanoparticle complex via incorporation of crystallization inhibitor at the nanoparticle formation step: A case of HPMC versus PVP. Dong B; Lim LM; Hadinoto K Eur J Pharm Sci; 2019 Oct; 138():105035. PubMed ID: 31386892 [TBL] [Abstract][Full Text] [Related]
6. A new bioavailability enhancement strategy of curcumin via self-assembly nano-complexation of curcumin and bovine serum albumin. Yu H; Nguyen MH; Cheow WS; Hadinoto K Mater Sci Eng C Mater Biol Appl; 2017 Jun; 75():25-33. PubMed ID: 28415461 [TBL] [Abstract][Full Text] [Related]
7. Enhancing the stability of amorphous drug-polyelectrolyte nanoparticle complex using a secondary small-molecule drug as the stabilizer: A case study of ibuprofen-stabilized curcumin-chitosan nanoplex. Lim LM; Hadinoto K Int J Pharm; 2020 Feb; 575():119007. PubMed ID: 31893545 [TBL] [Abstract][Full Text] [Related]
8. High-Payload Buccal Delivery System of Amorphous Curcumin-Chitosan Nanoparticle Complex in Hydroxypropyl Methylcellulose and Starch Films. Lim LM; Hadinoto K Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502305 [TBL] [Abstract][Full Text] [Related]
9. Millifluidic synthesis of amorphous drug-polysaccharide nanoparticle complex with tunable size intended for supersaturating drug delivery applications. Tran TT; Nguyen MH; Tan YZ; Chew JW; Khan SA; Hadinoto K Eur J Pharm Biopharm; 2017 Mar; 112():196-203. PubMed ID: 27903456 [TBL] [Abstract][Full Text] [Related]
10. Lyophilization of Curcumin-Albumin Nanoplex with Sucrose as Cryoprotectant: Aqueous Reconstitution, Dissolution, Kinetic Solubility, and Physicochemical Stability. Chua A; Tran TT; Pu S; Park JW; Hadinoto K Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233033 [TBL] [Abstract][Full Text] [Related]
11. A supersaturating delivery system of silibinin exhibiting high payload achieved by amorphous nano-complexation with chitosan. Nguyen MH; Yu H; Dong B; Hadinoto K Eur J Pharm Sci; 2016 Jun; 89():163-71. PubMed ID: 27140843 [TBL] [Abstract][Full Text] [Related]
12. A trade-off between solubility enhancement and physical stability upon simultaneous amorphization and nanonization of curcumin in comparison to amorphization alone. Wong JJL; Yu H; Lim LM; Hadinoto K Eur J Pharm Sci; 2018 Mar; 114():356-363. PubMed ID: 29309874 [TBL] [Abstract][Full Text] [Related]
13. Amorphous nanoparticle complex of perphenazine and dextran sulfate as a new solubility enhancement strategy of antipsychotic perphenazine. Dong B; Hadinoto K Drug Dev Ind Pharm; 2017 Jun; 43(6):996-1002. PubMed ID: 28121189 [TBL] [Abstract][Full Text] [Related]
14. Carboxymethyl cellulose is a superior polyanion to dextran sulfate in stabilizing and enhancing the solubility of amorphous drug-polyelectrolyte nanoparticle complex. Dong B; Hadinoto K Int J Biol Macromol; 2019 Oct; 139():500-508. PubMed ID: 31386874 [TBL] [Abstract][Full Text] [Related]
15. A Potential Quorum-Sensing Inhibitor for Bronchiectasis Therapy: Quercetin-Chitosan Nanoparticle Complex Exhibiting Superior Inhibition of Biofilm Formation and Swimming Motility of Tran TT; Hadinoto K Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33546487 [TBL] [Abstract][Full Text] [Related]
16. Crystalline Ethylene Oxide and Propylene Oxide Triblock Copolymer Solid Dispersion Enhance Solubility, Stability and Promoting Time- Controllable Release of Curcumin. Alves TFR; das Neves Lopes FCC; Rebelo MA; Souza JF; da Silva Pontes K; Santos C; Severino P; Junior JMO; Komatsu D; Chaud MV Recent Pat Drug Deliv Formul; 2018; 12(1):65-74. PubMed ID: 29345599 [TBL] [Abstract][Full Text] [Related]
17. Curcumin amorphous solid dispersions benefit from hydroxypropyl methylcellulose E50 to perform enhanced anti-inflammatory effects. Zhang J; Shi X; Tao W Int J Biol Macromol; 2023 Dec; 252():126507. PubMed ID: 37633564 [TBL] [Abstract][Full Text] [Related]
18. Polyelectrolyte Complex Nanoparticles from Chitosan and Acylated Rapeseed Cruciferin Protein for Curcumin Delivery. Wang F; Yang Y; Ju X; Udenigwe CC; He R J Agric Food Chem; 2018 Mar; 66(11):2685-2693. PubMed ID: 29451796 [TBL] [Abstract][Full Text] [Related]
19. Curcumin-polymeric nanoparticles against colon-26 tumor-bearing mice: cytotoxicity, pharmacokinetic and anticancer efficacy studies. Chaurasia S; Chaubey P; Patel RR; Kumar N; Mishra B Drug Dev Ind Pharm; 2016; 42(5):694-700. PubMed ID: 26165247 [TBL] [Abstract][Full Text] [Related]
20. Combining inkjet printing and amorphous nanonization to prepare personalized dosage forms of poorly-soluble drugs. Cheow WS; Kiew TY; Hadinoto K Eur J Pharm Biopharm; 2015 Oct; 96():314-21. PubMed ID: 26325060 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]